Detecting Lung Cancer Blog

Gaining awareness and eventually adoption even for breakthrough technologies is difficult in many markets, including revolutionary advances in medicine.

That is one reason why this article from Forbes makes an interesting point. With many new medical advancements, it is important to stay abreast of innovative technologies, even if they may not be part of every medical practice, and discuss them with your physician. It is important to remember that physicians, like all of us, fall into a routine that is comfortable for them and may not be quick to stray from that.

Lung cancer is a terrible disease. As the number one cancer killer in the United States, it claims the lives of half of all newly diagnosed patients in the first year alone.

According to data from the National Cancer Institute, however, finding lung cancer early raises the 5-year survival rate from just 15% to more than 50%. Because of this, it is important for people to be aware of available methods for early lung cancer detection.

Oncimmune’s EarlyCDT-Lung test, a blood test to aid in early lung cancer detection, celebrated the two-year anniversary of its commercial release last month.

During that time, the test has been used by thousands of patients and hundreds of doctors across the United States, helping to find numerous early stage lung cancers.

Below is a copy of the recent news release from PR Web, highlighting the anniversary of the test’s commercial release, and discussing how the test works, as well as how it has helped many people during its run on the market.

Tuesday was the World No Tobacco Day, and St. Louis teens pledged to stay away from the dangerous substance.

This is a good cause to rally behind, as tobacco use accounting for up to 90% of lung cancer. Though some of this can be attributed to 2^nd hand smoke, the primary cause comes from being a current or past smoker.